Danone has filed suit against Chobani over how the latter markets its high-protein yogurt products, escalating a long-running rivalry between two of the biggest names in American dairy. The complaint, filed June 15 in the Southern District of New York, alleges Chobani inflates protein claims on its 32-ounce containers of Chobani 20G Protein by setting a serving size of 6.7 ounces rather than the 5.3-ounce industry standard — a calculation that lets the product carry a "20 grams of protein" claim while comparing directly to Danone's Oikos Pro line, which hits the same gram count at the standard serving size.
The conventional read on a suit like this is that it's petty corporate squabbling — two giants fighting over shelf space while consumers shrug. But the protein category has become one of the most lucrative battlegrounds in packaged food, and the labels on those tubs increasingly function as the entire marketing pitch. A gram-count dispute is really a fight over who gets to define what "high-protein" means at retail.
This is the latest chapter in a legal relationship that stretches back a decade. Danone has sued Chobani at least three times since 2016, including a 2016 false advertising case over Chobani's "Simply 100" comparison campaign and a July 2025 trademark suit, also filed in the Southern District of New York, accusing Chobani of copying SToK cold brew's "Bright & Mellow" branding on La Colombe products. Chobani bought La Colombe for $900 million in December 2023, and several of the disputes since have involved products from the acquired brand.
The yogurt case lands at a moment when protein has eclipsed almost every other functional claim on packaging. Greek yogurt built its category dominance on the protein story, and brands have pushed the numbers higher — 15 grams, 20 grams, 25 grams per serving — to capture shoppers chasing GLP-1-era nutrition advice and gym-floor macros. The labels have gotten louder. Danone's complaint argues that Chobani's loudness crosses into territory that misleads consumers about what they're actually buying.
What's worth watching is how courts treat protein claims going forward. The FDA has rules about "high" and "good source" protein labeling tied to daily value percentages, but the marketing language wrapped around those claims — the fonts, the front-of-pack callouts, the comparative framing — sits in a grayer zone. A ruling in either direction could reshape how the whole category talks about itself.
For the plant-based aisle, the case has knock-on implications. Dairy-alternative yogurt brands have spent years trying to close the protein gap with Greek yogurt, often using pea, soy, or fava bean protein to hit comparable numbers. If the regulatory and legal scrutiny around dairy protein claims tightens, it raises the bar for plant-based competitors too — and clarifies the rules of engagement for newer entrants trying to win shelf space on a macro pitch.
The deeper question sitting underneath the lawsuit is who profits from the protein arms race. Shoppers are paying premium prices for incremental grams. Brands are reformulating around a single nutrient while sidelining broader conversations about fiber, fermentation, and whole-food quality. Litigation between Danone and Chobani won't settle any of that. It will, however, force a court to draw a line on how far a label can stretch before the claim stops being information and starts being something else.
